182 publications
Name | Date | Type | Actions |
---|---|---|---|
2013 3rd quarter sales show organic growth Vétoquinol generated sales of €74.0 million in the 3rd quarter of 2013, a drop of 0.1% based on reported data, and a 4.4% increase at constant exchange rates. |
24/10/2013 | Public releases | |
The reference products demonstrate solid growth Lure (France), August 29, 2013 – At its meeting on August 27, 2013, the Vétoquinol S.A. Board of Directors reviewed the Group’s results, and approved the financial statements for the first six months of 2013. |
29/08/2013 | Public releases | |
Q2 2013 sales Vétoquinol posted Q2 2013 sales of €70 million, up 0.3% on reported figures and up 1.4% like for like. |
16/07/2013 | Public releases | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2012 (french version) The registration document of Vétoquinol relative to fiscal year 2012, including the annual financial report relative to fiscal year 2012, was registered with the Autorité des marchés financiers (“the AMF”) on April 15th, 2013. |
16/04/2013 | Public releases | |
Q1 2013 sales Lure, April 16, 2013 – Vétoquinol posted Q1 2013 sales of €75.5 million, compared to €77.0 million for the first quarter of 2012. Like-for-like sales amounted to €76.0 million, compared to €77.0 million in Q1 2012. |
16/04/2013 | Public releases | |
2012, return to growth Lure, March 26, 2013 – The Vétoquinol Board meeting of March 7, 2013 reviewed the Group's business and approved the 2012 financial statements. |
26/03/2013 | Public releases | |
2012 sales up 5.0% Lure (France), January 24, 2013 – Vétoquinol posted 2012 sales of €298.3 million, up 5.0% compared to the previous year. At constant exchange rates, annual sales increased by 3.0%. |
24/01/2013 | Public releases | |
Forcyl® - a booming brand Lure (France), November 14, 2012 – Vétoquinol receives a new indication for its Forcyl® product, designed for cattle, and a new market authorization for Forcyl® Swine for pigs. |
14/11/2012 | Public releases | |
Sales momentum continues in Q3 Vétoquinol posted sales of €220.9 million for the first 9 months of 2012, up 6.2% compared to the same period last year. |
25/10/2012 | Public releases | |
Vétoquinol purchases ORSCO laboratoire vétérinaire Lure (France), September 25, 2012 – Vétoquinol announces the purchase of the entire equity of Orsco Laboratoire Vétérinaire. |
25/09/2012 | Public releases | |
Vétoquinol returns to growth Lure (France), 29 August 2012 – At its 29 August 2012 meeting, the Vétoquinol S.A. board of directors reviewed the Group results and approved the financial statements for the first six months of 2012. |
29/08/2012 | Public releases | |
Solid first half 2012 Sales First half 2012 sales reached €146.8 million, up 5.1% over first half 2011. |
17/07/2012 | Public releases | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2011 (french version) The registration document of Vétoquinol relative to fiscal year 2011, including the annual financial report relative to fiscal year 2011, was registered with the Autorité des marchés financiers (“the AMF”) on April 20th, 2012. |
23/04/2012 | Public releases | |
Strong Revenue growth in the first quarter of 2012 Vétoquinol achieved Q1 2012 sales of €77.0 million, up 15.9% compared to Q1 2011. |
20/04/2012 | Public releases | |
2011 annual earnings Lure (France), April 03, 2012 – The Vétoquinol Board Meeting of March 26, 2012 has reviewed the Group’s business and approved the 2011 financial statements. |
03/04/2012 | Public releases | |
Flevox® the new parasiticide for dogs and cats Lure (France), 14 February 2012 – Vétoquinol launches Flevox®, the latest addition to its range of parasiticides. The new drug is based on fipronil, the molecule par excellence in the treatment of tick and flea infestations in pets. |
14/02/2012 | Public releases | |
2011, a year of transition Lure (France), January 24, 2012 – In 2011, Vétoquinol achieved sales of €284.1 million, 0.7% up on the previous year and stable on a like-for-like basis. |
24/01/2012 | Public releases | |
Q3 2011 Sales Vétoquinol achieved Q3 2011 sales of €68.4 million, in line with the previous year. |
25/10/2011 | Public releases | |
Jacques du Puy appointed Vétoquinol Managing Director Lure (France), October 12, 2011 – The Vétoquinol Group announces the appointment |
12/10/2011 | Public releases | |
Forcyl®: european launch of new drug Lure (France), September 29, 2011 – Vétoquinol announces the European launch of Forcyl®, a new drug based on 16% concentrated marbofloxacin allowing the treatment of cattle respiratory infections with a single injection. |
29/09/2011 | Public releases | |
Vétoquinol continues to develop its product ranges and enters the brazilian market Lure (France), August 30, 2011 – The Vetoquinol Board Meeting of August 29, 2011 reviewed the Group’s business and approved the financial statements for the first half 2011. |
30/08/2011 | Public releases | |
International expansion and new product launches Lure (France), July 19, 2011 – Vétoquinol Group sales rose to €139.7 million in the first six months of 2011. |
19/07/2011 | Public releases | |
European launch of new Nsaid Cimalgex® Lure (France), June 14, 2011 – Vetoquinol announces the European launch of CIMALGEX®, a new treatment for pain and inflammation in dogs. |
14/06/2011 | Public releases | |
VÉTOQUINOL enters the brazilian Market Lure (France), June 7, 2011 – Vetoquinol announces the acquisition of 100% of the equity of Farmagricola SA in Brazil. |
07/06/2011 | Public releases | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2010 (french version) The registration document of Vétoquinol relative to fiscal year 2010, including the annual financial report relative to fiscal year 2010, was registered with the Autorité des marchés financiers (“the AMF”) on April 18th, 2011. |
27/04/2011 | Public releases | |
Net Sales rise 3% to €66.4 Million in the first Quarter of 2011 The Vétoquinol group reported a 3.0% rise in first quarter 2011 net sales to €66.4 million, compared to the same period last year. |
19/04/2011 | Public releases | |
2010 annual earnings Lure (France), April 4, 2011 – Vétoquinol’s Board of Directors, meeting on March 18, 2011, has reviewed the Group’s business and approved its 2010 financial statements. |
04/04/2011 | Public releases | |
Redemption of tranche B bonds Lure, 28 February 2011 – Vétoquinol S.A. has announced the redemption of the 58,927 tranche B bonds reaching maturity on 27 February 2011, by their conversion into common shares. |
28/02/2011 | Public releases | |
2010 Revenues grow 11.8%, driven by organic growth The Vétoquinol Group reports sustained sales growth driven by its “hybrid” business model, supported by a sound level of organic growth. |
25/01/2011 | Public releases | |
Vétoquinol markets CEFTIOCYL® and KEFLORIL® two new injectable antibiotics for livestock Lure, December 15, 2010 – In line with recent announcements, Vétoquinol is |
15/12/2010 | Public releases | |
November 30, 2010 (Lure, France) – Vétoquinol has appointed Régis Vimal du Monteil as |
30/11/2010 | Public releases | |
Vétoquinol registers its injectable Marbocyl® 2% and Marbocyl® 10% antibiotics in Japan November 18, 2010 (Lure, France) – Vétoquinol has just obtained Marketing |
18/11/2010 | Public releases | |
Strong Sales in the 3rd Quarter of 2010 Vétoquinol’s revenues for the third quarter of 2010 rose by 10.8%. This healthy rate of growth was attributable mainly to strong performance in the Group’s strategic regions and therapeutic segments. |
19/10/2010 | Public releases | |
Mise à disposition ou de consultation du rapport financier semestriel 2010 (french) Le Rapport financier semestriel 2010 de Vétoquinol peut être consulté ou téléchargé sur |
17/09/2010 | Public releases | |
Strong Results in the first half of 2010 The Board of Directors of Vétoquinol, meeting on August 30, reviewed the group’s business and approved its interim 2010 financial statements. |
30/08/2010 | Public releases | |
Continued Sales Growth in the second Quarter of 2010 Vétoquinol recorded strong sales growth (+15.1%) in the first six months of 2010, driven mainly by an increase in organic growth. |
16/07/2010 | Public releases | |
BOREVE-D: Vétoquinol is participating in a project to raise awareness of the need to treat pain in cattle June 30, 2010 (Lure, France) – Vétoquinol, in collaboration with two other veterinary laboratories, is participating in a project organised by the Syndicat de l’Industrie du Médicament Vétérinaire (SIMV) to raise awareness of the need to treat pain in cattle. |
30/06/2010 | Public releases | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2009 (french version) The registration document of Vétoquinol relative to fiscal year 2009, including the annual financial report relative to fiscal year 2009, was registered with the Autorité des marchés financiers (“the AMF”) on April 22th, 2010. |
23/04/2010 | Public releases | |
Continued sales growth driven by sustained organic growth April 22, 2010 (Lure, France) - Vétoquinol recorded a significant increase in sales in the first quarter of 2010, driven by sustained organic growth and the contribution of its Indian acquisition. |
22/04/2010 | Public releases | |
Departure of Pierre Konareff April 14, 2010 (Lure, France) – The Vétoquinol Group today announces the departure of Pierre |
14/04/2010 | Public releases | |
2009 annual earnings March 31, 2010 – (Lure, France) – Vétoquinol’s Board of Directors, meeting on March 11, 2010, reviewed the Group’s business and approved its 2009 financial statements. |
31/03/2010 | Public releases | |
Redemption of tranche A bonds February 26, 2010 (Lure, France) - Following the decision of Soparfin (family holding Etienne Frechin) not to convert the tranche A convertible bonds when they reach maturity on February 27, 2010, Vétoquinol has redeemed the bonds. |
26/02/2010 | Public releases | |
Strong growth in 2009 Revenues: +7.6% January 20, 2010 (Lure, France) - Vétoquinol recorded strong sales growth in 2009, despite an unfavourable exchange rate effect. The strength in sales is explained to a large extent by the contribution of acquisitions in Italy and India and by the resumption of organic growth, which held firm in the second half of 2009 despite the continuing weakness in the general economy. Revenues increased in all therapeutic classes and all geographic regions. |
20/01/2010 | Public releases | |
VÉTOQUINOL and JANSSEN ANIMAL HEALTH finalize an agreement for the exclusive distribution of SUROLAN® in the United States January 14, 2010 (Lure, France) – As part of its strategy of expanding its sales in the American market, Vétoquinol is pleased to announce an agreement with Janssen Animal Health to distribute Surolan® in the United States, following its approval by the FDA in December 2009. Surolan® is a leading example of Vétoquinol’s strategic focus on anti-infective agents and its success in this area. Surolan® has an excellent reputation in Europe, where it has been a great success. |
14/01/2010 | Public releases | |
Matthieu Frechin named Managing Director of Vétoquinol December 14, 2009 (Lure, France) – The Board of Directors of Vétoquinol, at its December 10 |
15/12/2009 | Public releases | |
Strong growth in Revenues in the 3rd quarter Vétoquinol recorded strong growth in the 3rd quarter of 2009, despite an unfavourable exchange rate effect. The strength in sales was due to a combination of the contribution of acquisitions in Italy and India and sustained organic growth. |
14/10/2009 | Public releases | |
Vétoquinol posts resilient results in the first half of 2009 and continues to pursue its international growth The Board of Directors of Vétoquinol, meeting on August 27, reviewed the group’s business and approved the group’s interim 2009 financial statements. |
31/08/2009 | Public releases | |
Vétoquinol completes the acquisition of Wockhardt Animal Health in India August 20, 2009 (Lure, France) – Vétoquinol today announced the completion of its acquisition of the animal health business division of Wockhardt Limited, based in Mumbaï, India. This acquisition was the subject of an agreement signed with the Wockhardt Limited group on June 26. |
20/08/2009 | Public releases | |
Growth in Revenues in the first half of 2009 Vétoquinol’s revenues in the first half of 2009 totalled EUR 119.9 million, an increase of 2.7% compared to the first half of the preceding year. |
16/07/2009 | Public releases | |
Vétoquinol enters the indian market June 29, 2009 (Lure, France) – Vétoquinol today announced the signing of an agreement for the acquisition of the Animal Health Division of Wockhardt Limited, based in Mumbaï, India. |
29/06/2009 | Public releases | |
Modalité de mise à disposition ou consultation du rapport annuel financier 2008 (french) Le Rapport annuel financier 2008, peut être consulté ou téléchargé |
04/05/2009 | Public releases | |
2009 Revenue improvement in trends in the first quarter Vétoquinol’s revenue for the first quarter of 2009 reached €57.1 M, an increase of 4.4% over the first quarter of 2008. |
09/04/2009 | Public releases | |
2008 annual earnings The Vétoquinol Board of Directors, meeting on March 20, 2009, reviewed the group’s business and approved the group’s 2008 financial statements. |
31/03/2009 | Public releases | |
Information relative à un engagement du Conseil d’Administration pris au bénéfice du Directeur Général Délégué Groupe (french) Lors de sa réunion du 13 mars 2009, le Conseil d’Administration a pris l’engagement, dans le cadre de la loi du 21 août 2007, de verser une indemnité à Monsieur Dominique HENRYON, Directeur Général Délégué Groupe, en cas de révocation de ce dernier pour tout autre motif qu’une faute grave. Cette décision se substitue à celle du 1er décembre 1998. |
30/03/2009 | Public releases | |
2008 revenue: €234.4 M Revenue grew in 2008, despite poor economic conditions in the second half and |
22/01/2009 | Public releases | |
Mis en oeuvre des recommandations AFEP/MEDEF du 6 octobre 2008 sur les rémunérations des dirigeants mandataires sociaux des sociétés cotées Lors de sa réunion du 5 décembre 2008, le Conseil d’administration a pris connaissance des recommandations AFEP-MEDEF du 8 octobre 2008 sur la rémunération des dirigeants sociaux des sociétés cotées. |
22/12/2008 | Public releases | |
Vétoquinol strengthens its position in Europe with the acquisition of Ascor Chimici in Italy Vétoquinol announces the signing of a contract to acquire 100 percent of the shares of Ascor Chimici S.r.l, which will take effect on 1 December 2008. |
25/11/2008 | Public releases | |
Revenues for the first nine months of 2008 Revenues increased by 3.1% during the first 9 months of 2008 to 171.2 million euros (4.8% on a like-for-like basis). |
22/10/2008 | Public releases | |
Vétoquinol: 2008 results expected to be in line with objectives At its meeting of 25 August 2008, the Board of Directors of Vétoquinol S.A. reviewed the Group’s operations and approved the financial statements for |
27/08/2008 | Public releases | |
2008 Interim Revenues increase by 5% Vétoquinol generated revenues of 116.7 million euros in the first half of 2008, a 5% increase over the 111.1 million euros |
22/07/2008 | Public releases | |
Pierre Konareff est nommé Directeur Financier et Juridique du Groupe Vétoquinol (french) Vétoquinol annonce la nomination de Pierre Konareff au poste de Directeur Financier et Juridique du groupe. |
08/07/2008 | Public releases | |
Vétoquinol strengthens its presence in Canada in the compagnion animal market Vétoquinol announces the acquisition of the animal health business assets of VETCOM 1979 INC. The animal health business of VETCOM 1979 INC. includes annual revenue of around CAD1.5 million. The company covers nearly 65% of the market for ophthalmological unguents in Canada. |
01/07/2008 | Public releases | |
Satisfactory revenue growth for 1st quarter 2008: +4.6% on a constant basis Revenue for the first quarter of 2008 reached €54.7 M, an increase of 3.0% over the first quarter of 2007, a high revenue growth period. First quarter 2008 growth was particularly significant for the livestock segment. |
06/05/2008 | Public releases | |
Earnings for 2007 attest to strength of business growth model The Vétoquinol board of directors, meeting on February 22, 2008, reviewed the group’s business in 2007 and approved the related financial statements. In 2007, Vétoquinol once again achieved significant improvement in its key performance |
18/03/2008 | Public releases | |
VÉTOQUINOL S.A. and JUROX PTY LTD extend their collaboration on ALFAXAN® in Europe |
17/03/2008 | Public releases | |
KIBOW BIOTECH INC. et Vétoquinol S.A. étendent leur accord de commercialisation et de licence vétérinaire pour des applications mondiales (french) |
25/02/2008 | Public releases | |
Revenue grows by 10.3% in 2007, to €233.4 M |
24/01/2008 | Public releases | |
Vétoquinol announces opening of its first decentralized R&D center in Canada |
17/12/2007 | Public releases | |
Vétoquinol to market and distribute Vetprofen in the United States |
28/11/2007 | Public releases | |
3rd quarter revenues confirm promise of For the nine months ended September 30, 2007, Vétoquinol’s total revenues reached €166.0 M, an increase of 11.3% compared with the |
25/10/2007 | Public releases | |
Reports very good first half, confirming that 2007 performance is set to surpass targets |
27/09/2007 | Public releases | |
Presentation of Vétoquinol’s results for the first half of 2007 2007 Half year results |
27/09/2007 | Public releases | |
Rapport semestriel 2007 « narratif » (french) Suite à la publication du 26 juillet dernier, Vétoquinol a réalisé au 1er semestre 2007 un |
31/08/2007 | Public releases | |
Business is strong in first-half of 2007 : + 12.9% 2007 Half year Financial Report |
26/07/2007 | Public releases | |
Vétoquinol creates a subsidiary in Portugal |
05/07/2007 | Public releases | |
2006 Financial Report Le chiffre d’affaires s’est accru de 7,6% par rapport à l’exercice précédent. |
04/06/2007 | Public releases | |
Activity Report 2006 |
04/06/2007 | Public releases | |
Annual earnings for 2006: a year of good performance |
23/04/2007 | Public releases | |
Présentation des résultats 2006 de Vétoquinol (french) |
23/04/2007 | Public releases | |
Vétoquinol reports one of its industry’ strongest growth performances in 2006 |
03/04/2007 | Public releases | |
Sustained revenue growth in 2006 |
15/02/2007 | Public releases | |
Vétoquinol strengthens its position in the United States |
02/01/2007 | Public releases |